Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Scope of the Report: This report focuses on the Erythropoietin in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application. Market Segment by Manufacturers, this report covers Amgen Johnson & Johnson Roche Galenica Emcure Kyowa Hakko Kirin 3SBio Biocon LG Life Sciences Market Segment by Countries, covering China Japan Korea Taiwan Southeast Asia India Australia Market Segment by Type, covers Epoetin-alfa Epoetin-beta Darbepoetin-alfa Others Market Segment by Applications, can be divided into Anemia Kidney Disorders Others There are 19 Chapters to deeply display the Asia-Pacific Erythropoietin market. Chapter 1, to describe Erythropoietin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Erythropoietin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Erythropoietin, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application; Chapter 14, Erythropoietin market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 17, to describe sales channel, distributors, traders, dealers etc. Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Erythropoietin Introduction 1.2 Market Analysis by Type 1.2.1 Epoetin-alfa 1.2.2 Epoetin-beta 1.2.3 Darbepoetin-alfa 1.2.4 Others 1.3 Market Analysis by Applications 1.3.1 Anemia 1.3.2 Kidney Disorders 1.3.3 Others 1.4 Market Analysis by Countries 1.4.1 China Status
